Response to: Debate in relation to “Ultra‑processed foods and human health: the main thesis and the evidence” - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Clarification on the Discussion Surrounding "Ultra-Processed Foods and Their Impact on Human Health: Key Arguments and Supporting Evidence

  • By

  • Leandro F. M. Rezende

  • Maria Laura da Costa Louzada

  • Euridice Martinez-Steele

  • Geoffrey Cannon

  • Renata B. Levy

  • Patricia C. Jaime

  • Carlos A. Monteiro

  • September 29, 2026

Share

  • 1

    Critics argue that ultra-processed foods (UPFs) form a biochemically incoherent category, complicating causal inference and policy development.

  • 2

    Dietary pattern approaches are essential for understanding health effects, as they reflect real-world food combinations rather than isolated nutrient analysis.

  • 3

    UPFs are associated with harmful attributes, including excessive energy density and additives, which are not present in traditional healthy diets.

  • 4

    Epidemiological studies show that UPF consumption correlates with chronic diseases, even after adjusting for traditional diet quality measures.

  • 5

    Criticism of evidence comparing UPFs to minimally processed foods overlooks the real-world dietary shifts from traditional diets to UPFs.

Original Source(s)

Response to: Debate in relation to “Ultra‑processed foods and human health: the main thesis and the evidence”

  • by Leandro F. M. Rezende, Maria Laura da Costa Louzada, Euridice Martinez-Steele, Geoffrey Cannon, Renata B. Levy, Patricia C. Jaime, Carlos A. Monteiro

  • September 29, 2026

Related Content

Current Status and Associated Factors of Technophobia Toward Digital Health Technologies Among Older Patients With Stroke: Mixed Methods Study

Evidence and Future Directions for Pediatric Health Care Chatbots: Systematic Review

FDA approves new treatment for FOP

Total new heterotopic ossification volume decreased with treatment and increased with placebo at week 24.